VIA

Virtus Investment Advisers Portfolio holdings

AUM $368M
1-Year Est. Return 26.25%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+26.25%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$349M
AUM Growth
+$53.4M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
478
New
Increased
Reduced
Closed

Top Buys

1 +$2.36M
2 +$1.99M
3 +$1.97M
4
IDXX icon
Idexx Laboratories
IDXX
+$1.96M
5
TKO icon
TKO Group
TKO
+$1.96M

Top Sells

1 +$1.85M
2 +$1.62M
3 +$1.62M
4
CBRE icon
CBRE Group
CBRE
+$1.61M
5
NU icon
Nu Holdings
NU
+$1.58M

Sector Composition

1 Financials 33.25%
2 Healthcare 17.27%
3 Technology 14.61%
4 Industrials 8.9%
5 Consumer Discretionary 5.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GHRS icon
401
GH Research
GHRS
$1.1B
$127K 0.04%
8,869
+1,540
NUVL icon
402
Nuvalent
NUVL
$8.17B
$126K 0.04%
1,461
+254
VIR icon
403
Vir Biotechnology
VIR
$1.65B
$124K 0.04%
21,798
+3,784
RCKT icon
404
Rocket Pharmaceuticals
RCKT
$426M
$121K 0.03%
37,064
+6,434
EWTX icon
405
Edgewise Therapeutics
EWTX
$3.55B
$120K 0.03%
7,380
+1,282
PCVX icon
406
Vaxcyte
PCVX
$8.95B
$119K 0.03%
3,302
+573
ELVN icon
407
Enliven Therapeutics
ELVN
$2.71B
$118K 0.03%
5,787
+1,004
SMMT icon
408
Summit Therapeutics
SMMT
$18.9B
$117K 0.03%
5,644
+980
WVE icon
409
Wave Life Sciences
WVE
$1.38B
$116K 0.03%
15,804
+2,744
IMVT icon
410
Immunovant
IMVT
$5.57B
$115K 0.03%
7,138
+1,239
RNAC icon
411
Cartesian Therapeutics
RNAC
$169M
$114K 0.03%
11,112
+1,929
DNLI icon
412
Denali Therapeutics
DNLI
$3.28B
$111K 0.03%
7,624
+1,324
BHVN icon
413
Biohaven
BHVN
$1.51B
$110K 0.03%
7,299
+1,267
CVAC
414
DELISTED
CureVac
CVAC
$110K 0.03%
20,319
+3,527
JANX icon
415
Janux Therapeutics
JANX
$924M
$109K 0.03%
4,452
+773
APGE icon
416
Apogee Therapeutics
APGE
$6.75B
$108K 0.03%
2,718
+472
SYRE icon
417
Spyre Therapeutics
SYRE
$5.49B
$108K 0.03%
6,425
+1,115
RGNX icon
418
Regenxbio
RGNX
$474M
$108K 0.03%
11,155
+1,936
RXRX icon
419
Recursion Pharmaceuticals
RXRX
$1.9B
$107K 0.03%
22,009
+3,821
KALV icon
420
KalVista Pharmaceuticals
KALV
$1B
$106K 0.03%
8,693
+1,509
SLN
421
Silence Therapeutics
SLN
$359M
$106K 0.03%
20,374
+3,537
VKTX icon
422
Viking Therapeutics
VKTX
$4.12B
$105K 0.03%
3,982
+692
BCYC
423
Bicycle Therapeutics
BCYC
$358M
$101K 0.03%
13,094
+2,273
AKRO
424
DELISTED
Akero Therapeutics
AKRO
$101K 0.03%
2,125
+369
ALLO icon
425
Allogene Therapeutics
ALLO
$578M
$101K 0.03%
81,276
+14,110